GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Resonate Blends Inc (OTCPK:KOAN) » Definitions » Valuation Rank

KOAN (Resonate Blends) Valuation Rank


View and export this data going back to 1993. Start your Free Trial

What is Resonate Blends Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Resonate Blends Valuation Rank Related Terms

Thank you for viewing the detailed overview of Resonate Blends's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Resonate Blends Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Resonate Blends Inc (OTCPK:KOAN) » Definitions » Valuation Rank
Comparable Companies
THCT SKYI ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 NSE:DIVISLAB XTAE:TEVA ITCI SZSE:000538 UTHR BOM:500087 TSE:4507 SHSE:688506 NSE:TORNTPHARM BOM:543904
Traded in Other Exchanges
N/A
Address
One Marine Plaza, Suite 305A, North Bergen, NJ, USA, 04047
Website
https://www.resonateblends.com
Resonate Blends Inc engages in the discovery, development and marketing of products designed to better mankind. The company believes It is positioning its company as a leader in the field of Regenerative Medicine defined by the National Institute of Health using nutritionally designed products. Intended products are to be marketed under third-party label exemptions. It is focusing its current efforts on marketing licensed patent-pending natural stem cell mobilizing agents capable of enhancing each individual's ability to mobilize their adult stem cells from their bone marrow.
Executives
Richard Hoge 10 percent owner C/O JIM KEARNEY, 760 SW 9TH AVE. STE 3000, PORTLAND OR 97205
Pamela Kerwin officer: Chief Operating Officer 26565 AGOURA ROAD, SUITE 200, CALABASAS CA 91302
Geoffrey Selzer director, officer: Chief Executive Officer 26565 AGOURA ROAD, SUITE 200, CALABASAS CA 91302
David Thomas Thielen 10 percent owner, officer: COO 1940 CONTRA COSTA BLVD., PLEASANT HILL CA 94523
Nick Allen Miniello 10 percent owner, officer: VP of Sales 1940 CONTRA COSTA BLVD., PLEASANT HILL CA 94523
Wais Asefi director, 10 percent owner, officer: CEO 1940 CONTRA COSTA BLVD., PLEASANT HILL CA 94523
Sterling John M Iii director
Gregory Oliver Sargent 10 percent owner 1609 FAIRFIELD BEACH ROAD, FAIRFIELD CT 06824
Steven Richard Deerwester officer: Vice President 3125 DARTMOUTH PLACE, CUMMING GA 30041
David G Kane other: Controller 50 JOE LEE DRIVE, SHARPSBURG GA 30277
I Sigmund Mosley director 945 E PACES FERRY RD, SUITE 2450, ATLANTA GA 30326
Vincent J Dooley director 2859 PACES FERRY ROAD, SUITE 1000, ATLANTA GA 30339
Spencer John N Jr director 2859 PACES FERRY RD, STE 1000, ATLANTA GA 30339
Marsha K Calfee officer: VP of Product Development
Jeffrey Longoria officer: VP of Sales